Shandong Sanyuan Biotechnology Co.Ltd. (301206) — Net Asset Quality Index
Shandong Sanyuan Biotechnology Co.Ltd. (301206) has a Net Asset Quality Index of 96.3% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥4.48 Billion minus total liabilities of CN¥166.97 Million yields net assets of CN¥4.31 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Read how much debt does Shandong Sanyuan Biotechnology Co.Ltd. carry for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Shandong Sanyuan Biotechnology Co.Ltd. Net Asset Quality Index Over Time (2013–2024)
This chart shows how Shandong Sanyuan Biotechnology Co.Ltd.'s Net Asset Quality Index has evolved across 12 annual periods from 2013 to 2024. As of September 2025, the index stands at 96.3%, representing net assets of CN¥4.31 Billion against total assets of CN¥4.48 Billion CNY. For live market cap and overall valuation, see 301206 market cap.
Annual Net Asset Quality Index for Shandong Sanyuan Biotechnology Co.Ltd. (2013–2024)
The table below presents the year-by-year Net Asset Quality Index for Shandong Sanyuan Biotechnology Co.Ltd. from 2013 to 2024, covering 12 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. See 301206 net asset value for net asset value and shareholders' equity analysis.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 93.5% | CN¥4.49 Billion | CN¥4.81 Billion | CN¥314.04 Million | ▼ -0.9 pp |
| 2023 | 94.3% | CN¥4.54 Billion | CN¥4.81 Billion | CN¥272.40 Million | ▼ -0.5 pp |
| 2022 | 94.9% | CN¥4.62 Billion | CN¥4.87 Billion | CN¥249.14 Million | ▲ +30.9 pp |
| 2021 | 64.0% | CN¥1.05 Billion | CN¥1.63 Billion | CN¥588.83 Million | ▼ -1.3 pp |
| 2020 | 65.3% | CN¥509.91 Million | CN¥781.39 Million | CN¥271.48 Million | ▼ -1.2 pp |
| 2019 | 66.5% | CN¥348.15 Million | CN¥523.74 Million | CN¥175.59 Million | ▲ +2.3 pp |
| 2018 | 64.2% | CN¥179.52 Million | CN¥279.63 Million | CN¥100.12 Million | ▲ +0.3 pp |
| 2017 | 63.9% | CN¥115.81 Million | CN¥181.12 Million | CN¥65.31 Million | ▼ -4.2 pp |
| 2016 | 68.2% | CN¥86.64 Million | CN¥127.08 Million | CN¥40.44 Million | ▲ +5.0 pp |
| 2015 | 63.2% | CN¥42.30 Million | CN¥66.95 Million | CN¥24.64 Million | ▲ +16.8 pp |
| 2014 | 46.4% | CN¥26.60 Million | CN¥57.27 Million | CN¥30.68 Million | ▼ -11.3 pp |
| 2013 | 57.7% | CN¥26.08 Million | CN¥45.18 Million | CN¥19.10 Million | — |